Treatment of type B insulin resistance with immunoglobulin: novel use of an old therapy

Huy A Tran and Glenn E Reeves
Med J Aust 2009; 190 (3): . || doi: 10.5694/j.1326-5377.2009.tb02335.x
Published online: 2 February 2009

To the Editor: Type B insulin resistance is an uncommon syndrome characterised by abnormal glucose homeostasis (hypo- and/or hyperglycaemia), the presence of insulin receptor (IRec) autoantibodies, and intact IRec structure. It occurs mostly in African Americans, often with coexisting autoimmune disease.1

  • Huy A Tran
  • Glenn E Reeves

  • Hunter Area Pathology Service, Newcastle University, Newcastle, NSW.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.